Global miRNA Market 2015-2019

Global miRNA Market 2015-2019

Category : Diagnostic and Biotech
Published On : November  2014
Pages : 80



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com
About miRNAs
miRNAs are single-stranded, small, non-coding RNA molecules that regulate gene expression at the translation level. They play a vital role in research, diagnostics, and therapeutics to study expression of genes and to control diseases by gene silencing. They interact with mRNA molecules and regulate expression of genes by mRNA cleavage, translational repression, and deadenylation. They are generally 17-27 nucleotides long and regulate post-transcriptional mRNA expression by binding to the 3’ untranslated region of the mRNA sequence, which results in translational suppression and gene silencing. miRNAs are involved in a wide range of biological processes, including apoptosis, cell cycle control, and several developmental processes such as stem cell differentiation, hypoxia, hematopoiesis, neurogenesis, insulin secretion, cardiac and skeletal muscle development, aging, cholesterol metabolism, viral replication, and immune responses. They can be used as therapeutics for the treatment of some severe diseases including cancer and genetic disorders by introducing specific miRNAs into diseased cells to silence the defective gene.  

TechNavio's analysts forecast the Global miRNA market to grow at a CAGR of 13.36 percent over the period 2014-2019.
Covered in this Report
The Global miRNA market can be divided into different segments based on application: miRNA Research, miRNA-based Diagnostics, and Therapeutics
TechNavio's report, Global miRNA Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global miRNA market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas 
• APAC        
• EMEA
Key Vendors
• Affymetrix
• Agilent Technologies 
• Exiqon 
• Qiagen
• Thermo Fisher Scientific 
Other Prominent Vendors
 
• Alnylam Pharmaceuticals 
• Aparna Biosciences
• Applied Biological Materials
• AstraZeneca Pharmaceuticals
• Biogen Idec
• Bio-Rad Laboratories
• F. Hoffmann-La Roche
• Firefly Bioworks
• Fluidigm
• Genecopoeia
• Genosensor
• Gensignia
• Glaxosmithkline
• Groove Biopharma
• HTG Molecular Diagnostics
• Idera Pharmaceuticals
• Illumina
• Integrated DNA Technologies
• InteRNA Technologies
• LC Sciences
• EMD Millipore
• Miltenyi Biotec
• miRagen Therapeutics
• Mirna Therapeutics
• Nanostring Technologies
• Norgen Biotek
• Novartis
• Origene Technologies
• Pfizer
• Phalanx Biotech
• Prolias Technologies
• Quark Pharmaceuticals
• Regulus Therapeutics
• Rosetta Genomics
• RXi Pharmaceuticals
• Sanofi
• Santaris Pharma (Acquired by Roche)
• Silence Therapeutics
• System Biosciences
• Takara Bio
• Tekmira Pharmaceuticals
• Theradiag
• WaferGen Biosystems
• Wako Pure Chemical Industries
Market Driver
• Increased Investment in miRNA-based Research and Drug Development 
• For a full, detailed list, view our report
Market Challenge
• Delivery of miRNA-based Drugs
• For a full, detailed list, view our report
Market Trend
• Increased M&A
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Application
07.1 Global miRNA Research Market
07.1.1 Market Size and Forecast
07.2 Global miRNA-based Diagnostics Market
07.2.1 Market Size and Forecast
07.3 Global miRNA-based Therapeutics Market
07.3.1 Pipeline Snapshot
08. Geographical Segmentation
08.1 miRNA Market in Americas
08.1.1 Market Size and Forecast
08.2 miRNA Market in EMEA Region
08.2.1 Market Size and Forecast
08.3 miRNA Market in APAC Region
08.3.1 Market Size and Forecast
09. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Trends and their Impact
16. Vendor Landscape
16.1 Competitive Scenario
16.1.1 Key News
16.1.2 Mergers and Acquisitions
16.2 Vendor Analysis 2013
16.3 Other Prominent Vendors
17. Key Vendor Analysis
17.1 Affymetrix Inc.
17.1.1 Key Facts
17.1.2 Business Overview
17.1.3 Business Segmentation
17.1.4 Business Segmentation by Revenue 2013
17.1.5 Business Segmentation by Revenue 2012 and 2013
17.1.6 Sales by Geography
17.1.7 Business Strategy
17.1.8 Key Information
17.1.9 SWOT Analysis
17.2 Agilent Technologies
17.2.1 Key Facts
17.2.2 Business Overview
17.2.3 Business Segmentation by Revenue 2013
17.2.4 Business Segmentation by Revenue 2012 and 2013
17.2.5 Geographical Segmentation by Revenue 2013
17.2.6 Business Strategy
17.2.7 Recent Developments
17.2.8 SWOT Analysis
17.3 Exiqon A/S
17.3.1 Key Facts
17.3.2 Business Overview
17.3.3 Business Segmentation by Revenue 2013
17.3.4 Business Segmentation by Revenue 2012 and 2013
17.3.5 Geographical Segmentation by Revenue 2013
17.3.6 Business Strategy
17.3.7 Recent Developments
17.3.8 SWOT Analysis
17.4 Qiagen
17.4.1 Key Facts
17.4.2 Business Overview
17.4.3 Product Segmentation by Revenue 2013
17.4.4 Product Segmentation by Revenue 2012 and 2013
17.4.5 Geographical Segmentation by Revenue 2013
17.4.6 Business Strategy
17.4.7 Recent Developments
17.4.8 SWOT Analysis
17.5 Thermo Fisher Scientific
17.5.1 Key Facts
17.5.2 Business Overview
17.5.3 Business Segmentation
17.5.4 Product Segmentation by Revenue
17.5.5 Sales Segmentation
17.5.6 Business Strategy
17.5.7 Key Information
17.5.8 SWOT Analysis
18. Other Reports in this Series

List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global miRNA Market 2014-2019 (US$ million)
Exhibit 3: Global miRNA Market Segmentation by Application
Exhibit 4: Global miRNA Research Market 2014-2019 (US$ million)
Exhibit 5: Global miRNA-based Diagnostics Market 2014-2019 (US$ million)
Exhibit 6: Global miRNA Market Segmentation by Application 2014-2019 (US$ million)
Exhibit 7: Global miRNA Market Segmentation by Application 2014-2019
Exhibit 8: Percentage split of the Global miRNA Therapeutics Pipeline 2013
Exhibit 9: Global miRNA Market Segmentation by Geography 2014
Exhibit 10: miRNA Market in Americas 2014-2019 (US$ million)
Exhibit 11: miRNA Market in EMEA Region 2014-2019 (US$ million)
Exhibit 12: miRNA Market in APAC Region 2014-2019 (US$ million)
Exhibit 13: Global miRNA Market Segmentation by Geography 2014-2019 (US$ million)
Exhibit 14: Global miRNA Market Segmentation by Geography 2014-2019
Exhibit 15: Affymetrix Inc.: Business Segmentation 2013
Exhibit 16: Affymetrix Inc. 2013: Business Segmentation by Revenue 2013
Exhibit 17: Affymetrix Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 18: Affymetrix Inc.: Sales by Geography 2013
Exhibit 19: Agilent Technologies: Business Segmentation by Revenue 2013
Exhibit 20: Agilent Technologies: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 21: Agilent Technologies: Geographical Segmentation by Revenue 2013
Exhibit 22: Exiqon: Business Segmentation by Revenue 2013
Exhibit 23: Exiqon: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 24: Exiqon: Geographical Segmentation by Revenue 2013
Exhibit 25: Qiagen: Product Segmentation by Revenue 2013
Exhibit 26: Qiagen: Product Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 27: Qiagen: Geographical Segmentation by Revenue 2013
Exhibit 28: Thermo Fisher Scientific: Business Segmentation by Revenue 2013
Exhibit 29: Thermo Fisher Scientific: Product Segmentation by Revenue 2013
Exhibit 30: Thermo Fisher Scientific: Sales by Geography 2013



Enquiry Before Buy
image
Can´t read the image ? refresh here.